Advertisements

Omeprazol Sandoz

Quick links to important sections

Omeprazol Sandoz

Selected form

Advertisements

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Omeprazol Sandoz

Property Description
Active ingredient Omeprazole (INN)
Form Delayed-release capsule / Enteric-coated tablet (Oral)
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Inhibition of gastric acid secretion
Origin Synthetic, substituted benzimidazole

What Type of Medicine is Omeprazol Sandoz and What is Its Class?

Omeprazol Sandoz is a medication containing the active ingredient Omeprazole, a synthetic compound belonging to the substituted benzimidazole chemical group. Omeprazole is pharmacologically classified as a Proton Pump Inhibitor (PPI), positioning it in the Antisecretory class of drugs. This classification signifies its primary action is to reduce the volume of acid produced by the stomach, a characteristic clinically recognized for its superior acid control compared to older receptor-blocking agents. The brand Sandoz indicates its association with a global manufacturer of high-quality pharmaceutical medicines.


Omeprazol Sandoz Composition and Delivery Form

The product is a single-component product, utilizing Omeprazole as its sole active pharmaceutical ingredient. It is designed for oral administration and is prepared as a delayed-release capsule or enteric-coated tablet. This specific gastro-resistant formulation is a necessity, ensuring that the active substance, which is chemically unstable in highly acidic conditions, bypasses the stomach intact. This specialized engineering allows the drug to be safely absorbed in the small intestine, where it can be distributed systemically to the target cells.


The General Purpose of This Antisecretory Agent

The fundamental purpose of this antisecretory agent is to achieve substantial and long-lasting inhibition of gastric acid secretion, thus systematically reducing the total volume of acid present in the stomach. The drug’s mechanism is highly effective in decreasing acid levels, resulting in a consistent and robust reduction of acidity. The resulting benefit is the mitigation of the harsh, corrosive effects of excess stomach acid throughout the upper digestive tract, often used to provide relief in scenarios involving acid discomfort or frequent regurgitation.

Advertisements

What side effects are possible with Omeprazol Sandoz?

Possible Side Effects and Safety Information

Omeprazole's safety profile is documented by regulatory authorities, with adverse reactions categorized by frequency and the physiological system affected. The most frequently observed reactions are generally associated with the gastrointestinal system and general disorders.


Frequency-Classified Adverse Reactions

Frequency Classification Examples of Documented Reactions (Not exhaustive)
Common (up to 1 in 10) Headache; gastrointestinal symptoms including abdominal pain, diarrhea, constipation, flatulence, nausea, and vomiting; development of benign gastric polyps.
Uncommon (up to 1 in 100) Insomnia, dizziness, somnolence, vertigo, paresthesia, rash, pruritus, urticaria, malaise, peripheral edema, transient increase in liver enzymes.

Serious Adverse Reactions and Systemic Effects

Reactions classified as rare or very rare involve more serious systemic effects. These include severe immune responses like hypersensitivity reactions (e.g., anaphylactic shock), significant hematological changes such as leukopenia or agranulocytosis, and severe skin reactions like Stevens-Johnson syndrome (SJS). Effects are documented across system-organ classes including the Nervous System, Hepatobiliary System (e.g., hepatitis, hepatic failure), and Renal System (e.g., interstitial nephritis).


Safety Considerations Related to Duration of Use

Specific safety concerns are noted regarding treatment duration. Hypomagnesemia (low blood magnesium levels), Vitamin B-12 deficiency, and an increased risk of bone fracture (hip, wrist, or spine) are documented as safety patterns associated with prolonged therapy. The medicine is contraindicated in patients with a known hypersensitivity to omeprazole or other substituted benzimidazoles. Symptomatic response to therapy does not preclude the presence of gastric malignancy.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with omeprazole, the active ingredient in Omeprazol Sandoz, is associated with a specific profile of documented clinical manifestations that are generally defined as transient by regulatory sources.

Documented Manifestations

The officially reported signs following overdosage may include gastrointestinal effects such as nausea, vomiting, abdominal pain, and diarrhea. Central Nervous System (CNS) effects that have been reported include headache, dizziness, confusion, and drowsiness (somnolence). Additionally, autonomic and systemic signs such as tachycardia (increased heart rate), flushing, diaphoresis (increased sweating), and dry mouth may occur.

Official regulatory documents consistently state that no serious clinical outcome has been reported, even following administration of significantly high exposures.

Required Emergency Actions

It is mandated to seek immediate medical attention for any suspected overdosage. Management is defined as symptomatic and supportive treatment, as regulatory agencies confirm that no specific antidote is known for omeprazole.

A procedural constraint noted in official labeling is that omeprazole is extensively protein bound and is, therefore, not readily dialyzable. Urgent medical help must also be sought immediately if signs of a severe allergic reaction are present.

Advertisements

Therapeutic Uses of Omeprazol Sandoz

What Omeprazol Sandoz Treats: Main Uses and Benefits

Omeprazol Sandoz is commonly used to help manage symptoms and conditions related to irritative or inflammatory states caused by excess gastric acid. Its therapeutic benefit is relevant for easing symptoms and generally supports the healing of tissues affected by acid-related diseases across several key domains.

The medication is commonly used to help manage the symptomatic manifestations of Gastroesophageal Reflux Disease (GERD) and persistent heartburn. It is also applied in conditions marked by acid-induced physical damage, including gastric ulcers, duodenal ulcers, and erosive esophagitis. Additionally, it is commonly used to help manage the risk of ulcers in patients requiring NSAID medications and is a component of combination therapy for H. pylori infection.

“The primary goal of this therapy is to ease the painful burning and discomfort caused by acid backflow, supporting the patient during difficult symptomatic phases.”

The medication may assist with managing symptoms and generally supports improved day-to-day comfort during periods of heightened symptoms. It is relevant for easing associated symptoms like epigastric pain and supports the natural healing of damaged tissues, helping to maintain stability during symptomatic phases.

Quick Fact: Relief for Acid-Related Symptoms
This medicine is commonly used when symptoms cluster into patterns requiring supportive management, such as frequent heartburn and acid regurgitation.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Omeprazol Sandoz?

The eligibility profile for Omeprazol Sandoz is strictly defined by government regulatory documentation (EMA, FDA), specifying patient groups who may use the medicine and those who must not.


Absolute Contraindications

Use of Omeprazol Sandoz is contraindicated and must be avoided in patients with a known hypersensitivity to the active substance, omeprazole, to other drugs in the substituted benzimidazole class, or to any ingredient in the formulation.

Patients currently receiving the antiviral agents nelfinavir or rilpivirine-containing products are also strictly non-eligible for treatment, as specified in regulatory labeling.


Eligibility by Age and Condition

Population Group Eligibility Status
Adults & Older Adults Fully eligible; no routine dose adjustment is needed for the elderly.
Children Eligible for specific uses (e.g., GERD, H. pylori) if ge 1 year of age and ge 10 kg. Use is generally not established in infants under one year.
Hepatic Impairment Requires caution; eligibility is conditional upon considering dose reduction.
Renal Impairment Eligible for standard use; no dose adjustment is needed.
Pregnancy/Lactation Eligibility is conditional; use should occur only when the benefit justifies the potential risk.

Additionally, eligibility for treatment of gastric ulcers requires the exclusion of gastric malignancy prior to commencing therapy.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Omeprazole affects the body's processing of other medicines primarily through two mechanisms documented in regulatory sources: reducing stomach acid and inhibiting the CYP2C19 enzyme.

Pharmacokinetic Interactions

  • Medicines Requiring Acidic pH for Absorption: Omeprazole reduces the absorption and effectiveness of drugs like atazanavir, nelfinavir, rilpivirine, ketoconazole, itraconazole, iron salts, and ampicillin esters. Use with rilpivirine is contraindicated, and use with atazanavir and nelfinavir is generally not recommended.
  • CYP2C19 Metabolized Medicines: Omeprazole inhibits CYP2C19, potentially increasing plasma concentrations of co-administered drugs like diazepam, phenytoin, cilostazol, and warfarin. Patients on warfarin require close monitoring of INR.
  • Clopidogrel: Concomitant use with this antiplatelet agent is not recommended as omeprazole significantly diminishes its active form, reducing its effectiveness.
  • Methotrexate: Omeprazole may increase the serum levels of methotrexate and its metabolite. Temporary cessation of omeprazole is generally considered during high-dose methotrexate therapy.

Other Notable Interactions

  • Inducers: The effectiveness of omeprazole may be reduced when taken with CYP2C19/ CYP3A4 inducers like rifampin or St. John's Wort.
  • Diagnostic Tests: Omeprazole use can increase Chromogranin A ( CgA) levels, potentially interfering with diagnostic tests for neuroendocrine tumors. Testing requires a period of temporary omeprazole withdrawal.
Advertisements

Mechanism of Action

Omeprazole functions as a lipophilic weak base prodrug, passively diffusing across cellular membranes before selectively accumulating within the highly acidic secretory canaliculi of the gastric parietal cells. In this acidic environment, the prodrug undergoes protonation and molecular rearrangement, converting into its active form, a sulfenamide derivative. This derivative acts as an irreversible inhibitor by forming a stable covalent bond with specific cysteine residues exposed on the luminal surface of the H^+/ K^+- ATPase enzyme, commonly known as the proton pump. This binding event permanently inactivates the enzyme, thereby preventing the final step of gastric acid ( HCl) secretion into the stomach lumen. The duration of this inhibition is determined by the turnover rate of the parietal cell's H^+/ K^+- ATPase complement, requiring the synthesis of new functional enzyme units to restore acid secretion.

Advertisements

Dosage and Administration Information

Omeprazol Sandoz is administered exclusively via the oral route, typically utilizing a delayed-release capsule or tablet. The medication's usage protocol is strictly tied to the integrity of its gastro-resistant formulation; therefore, the capsule or tablet must be swallowed whole with liquid and should not be crushed, chewed, or split, as this physical manipulation compromises the specialized coating essential for proper absorption in the small intestine. If swallowing is difficult, the capsule may be opened, the pellets mixed with a small amount of soft, cool food like applesauce, and the mixture must be swallowed immediately.

The medicine is generally scheduled to be taken once daily, preferably before a meal, most commonly in the morning, to align the drug’s inhibitory action with the physiological onset of acid secretion. Standard adult dosing regimens often fall in the range of 20 mg to 40 mg once daily for common conditions. For conditions requiring high-dose administration, such as pathological hypersecretory states, total daily doses exceeding 80 mg are generally administered as divided doses to optimize efficacy.

Usage Protocol Element Standard Labeled Instruction
Administration Route Oral (Delayed-Release Form)
Standard Frequency Once daily
Timing Taken before a meal, typically in the morning

Usage duration varies: acute treatment is typically short-term, lasting approximately 4 to 8 weeks, while some maintenance protocols may permit longer-term use. For patients with hepatic impairment, a reduced dose may be necessary, and 20 mg once daily may represent the maximum starting dose. If a dose is missed, it should be taken as soon as possible unless the next dose is nearly due, in which case the missed dose should be skipped; doubling the dose is explicitly not recommended.

Advertisements

Recent Clinical Evidence

Omeprazol Sandoz, a member of the proton pump inhibitor (PPI) class of medicines, works to reduce the amount of acid produced in the stomach. Clinical research primarily evaluates its role in managing conditions such as Gastroesophageal Reflux Disease (GERD), peptic ulcers, and in the treatment of Helicobacter pylori infection in combination with antibiotics.


Efficacy Data from Trials

Studies have assessed the medicine’s ability to promote the healing of erosive esophagitis (damage to the food pipe lining caused by stomach acid). In patients with this condition, research shows that most achieve healing within 4 to 8 weeks of treatment.

For maintenance therapy—used to prevent the return of symptoms and healing of the esophagus—trials compared Omeprazol Sandoz to other PPIs. These studies generally found similar efficacy in keeping patients symptom-free over extended periods, typically up to 6 to 12 months. Certain comparisons suggest that a 20 mg daily dose is associated with a greater rate of symptomatic relief compared to a 10 mg dose in patients with non-erosive reflux disease.


Safety and Long-Term Use

Clinical trials report that the most common side effects include headache, nausea, abdominal pain, diarrhea, and gas. These adverse events are usually mild and temporary.

Long-term use (over one year) is associated with an increased risk of specific health changes, including the potential for a decrease in vitamin B12 and magnesium levels, and an elevated risk of osteoporosis-related fractures. Due to the potential for these changes, regular monitoring is often recommended for patients on long-term treatment. Further research continues to track the full long-term safety profile of PPIs.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Omeprazol Sandoz (FAQ)


Q: How long after starting Omeprazol Sandoz can people expect to notice a difference?

According to official product information, Omeprazol begins to reduce the production of stomach acid within one hour of being taken. The maximum acid-blocking effect is typically reached within four days of beginning treatment. For conditions such as erosive esophagitis, clinical trials assessed that healing was generally achieved after four to eight weeks of treatment.


Q: What are some of the most common or frequently reported side effects of Omeprazol Sandoz?

The official safety profile states that the most common adverse reactions, occurring in up to 1 in 10 patients, include headache and gastrointestinal symptoms. These stomach and digestive issues include abdominal pain, diarrhea, constipation, flatulence (gas), nausea, and vomiting.


Q: Does Omeprazol Sandoz affect calcium or bone health over a long period?

Regulatory warnings indicate that prolonged, high-dose therapy, typically for one year or more, may be associated with an increased risk of bone fractures, particularly in the hip, wrist, or spine. Regulatory information emphasizes the importance of using the lowest effective dose for the shortest duration of therapy needed.


Q: Can taking Omeprazol Sandoz make people feel tired or dizzy?

The official safety profile documents dizziness and somnolence (drowsiness or tiredness) as uncommon adverse reactions, which means they occur in up to 1 in 100 patients. These effects are important to be aware of as they may impact activities requiring alertness.


Q: Is it true that Omeprazol Sandoz can interact with blood thinners?

Yes, official documents note that Omeprazol Sandoz is generally not recommended for use with the antiplatelet drug clopidogrel because it can reduce its effectiveness. Co-administration with the anticoagulant warfarin may also require closer monitoring of blood clotting time, often measured by INR.


Q: Are there any vitamins or supplements that are known to interact with Omeprazol Sandoz?

Official information states that the medicine's effectiveness may be reduced if taken with CYP inducers, such as the herbal supplement St. John's Wort. Furthermore, prolonged use is linked to potential decreases in essential nutrients like Vitamin B12 and magnesium, which may necessitate supplementation.


Q: Is Omeprazol Sandoz safe to take while pregnant or breastfeeding?

For pregnancy, extensive data suggests no adverse effects on the fetus, and Omeprazole is considered for use when a clinical need exists. During breastfeeding, Omeprazol is passed into breast milk, but official information indicates it is generally considered unlikely to pose a risk to the infant when used at therapeutic doses.


Q: Can Omeprazol Sandoz be used by children?

Yes, regulatory bodies permit its use for specific conditions, such as GERD and erosive esophagitis, in children who are one year of age or older and who weigh 10 kg or more. Its use is defined by specific guidelines related to the child’s weight and the condition being treated.


Q: What happens if someone forgets to take a dose of Omeprazol Sandoz?

Regulatory documents describe what to do if a dose is missed: it should be taken as soon as possible, unless the time for the next scheduled dose is approaching. If the next dose is almost due, the missed dose should be skipped entirely. Regulatory information explicitly warns against taking two doses to make up for a missed one.


Q: Can Omeprazol Sandoz cause a headache or stomach discomfort when first starting it?

Headache and gastrointestinal symptoms, including abdominal pain, nausea, and flatulence, are documented as Common adverse reactions in the safety profile. This means these effects may be among the first to be experienced when a person begins treatment, affecting up to 1 in 10 patients.


Q: What kind of research exists about the long-term use of Omeprazol?

Research themes described in regulatory documents primarily focus on the safety profile associated with prolonged use, generally over one year. These studies examine the potential for decreased Vitamin B12 and magnesium levels and the potential increased risk of bone fractures.


Q: Is it considered safe to stop taking Omeprazol Sandoz suddenly?

The concept of rebound acid hypersecretion—a temporary return of symptoms—can occur after stopping the medicine. Patients who have been on long-term therapy often find it helpful to discuss discontinuation with their prescriber to manage these potential effects.


Q: Can Omeprazol Sandoz cause a rash or skin reaction?

Yes. Skin reactions such as rash, itching, and hives are listed as uncommon side effects. Official safety documents also describe rare but serious skin reactions, including Stevens-Johnson syndrome (SJS), which is an adverse event that requires immediate medical attention.


Q: How is the safety of Omeprazol Sandoz for use in older adults described?

Regulatory bodies classify older adults as fully eligible for standard use of the medicine, and generally, no routine dose adjustment is required based on age alone. However, the general warnings about the risks associated with long-term use, such as bone fracture risk, still apply to this population.


Q: Is Omeprazol Sandoz approved for the treatment of GERD?

Yes. Official indications from regulatory authorities confirm that Omeprazol is approved for the treatment of Gastroesophageal Reflux Disease (GERD). This includes the healing of erosive esophagitis (damage to the food pipe lining) associated with the condition.


Q: What is the connection between Omeprazol Sandoz and B12 vitamin levels?

Official safety information notes that long-term daily use of Omeprazol, typically lasting two years or more, is associated with the potential for a decrease in Vitamin B12 levels. This connection is thought to be due to the significant reduction of stomach acid, which is necessary for the proper absorption of Vitamin B12 from food.


Q: Do you need a prescription to get Omeprazol Sandoz?

The availability of Omeprazole depends on the specific country and the product strength. In many regions, the medicine is available under two regulatory statuses: prescription-only for specific conditions or higher doses, and over-the-counter (OTC) for lower doses used for short-term heartburn relief. The requirement for a prescription depends entirely on the product being obtained.


Q: What are the official warnings or precautions listed for Omeprazol Sandoz?

Official warnings cover several key precautions. These include the need to rule out gastric malignancy (stomach cancer) before starting therapy, the risks of bone fracture and kidney injury (acute interstitial nephritis) with prolonged use, and the potential for Clostridioides difficile-associated diarrhea.


Q: Can Omeprazol Sandoz affect kidney function?

Regulatory documents describe that in rare instances, Omeprazol can be associated with a serious type of kidney injury known as acute interstitial nephritis ( AIN), which can happen at any point during therapy. However, for patients with pre-existing mild to moderate renal impairment, standard use does not typically require a dose adjustment.


Q: Is there a known link between long-term Omeprazol Sandoz use and stomach polyps?

The development of benign fundic gland polyps (non-cancerous growths) in the lining of the stomach is documented as a Common side effect. This is specifically associated with continuous use over a long period, typically defined as treatment lasting longer than one year.


Q: Does Omeprazol Sandoz help with a sore throat caused by reflux?

Omeprazole is officially indicated for treating GERD and erosive esophagitis, both of which are caused by acid reflux. By reducing acid production, the medicine can help address the symptoms associated with acid exposure in the esophagus.


Q: Why are people told to take Omeprazol Sandoz before a meal?

Regulatory guidance advises taking the medicine before a meal because the active substance works most effectively when the acid-producing cells in the stomach are stimulated by food. The timing ensures that the drug is available to inhibit the proton pumps as acid secretion begins.


Q: Can Omeprazol Sandoz affect magnesium levels?

Yes. Official safety warnings indicate that Hypomagnesemia (low blood magnesium levels), which can be severe, has been reported in patients treated with the medicine for three months or more. Regulatory guidance recommends that doctors consider monitoring magnesium levels in patients expected to be on long-term therapy.


Q: Can taking Omeprazol Sandoz influence the results of certain medical tests?

Yes, official safety information states that Omeprazole use can increase Chromogranin A ( CgA) levels in the blood. Since CgA is used in the diagnosis of certain neuroendocrine tumors, it is generally advised to temporarily stop taking the medicine prior to CgA testing to ensure accurate results.


Q: Does Omeprazol Sandoz contain lactose or gluten?

The excipients (inactive ingredients) used in the capsule or tablet formulations often include lactose and/or sucrose. This means the product may not be suitable for individuals with certain sugar intolerances. The core regulatory texts typically do not specify whether the product contains or is free of gluten.


Q: Is Omeprazol Sandoz known to cause diarrhea or constipation?

Yes. Both diarrhea and constipation are documented in the official safety profile as Common gastrointestinal adverse reactions. This means these digestive changes may be experienced by up to 1 in 10 patients.


Q: Can Omeprazol Sandoz be taken at the same time as other acid reducers?

The combination with other prescription acid blockers is generally not needed. However, official information states that antacids (which neutralize acid already present) can be taken simultaneously with omeprazole (which stops new acid production) if needed to manage breakthrough symptoms.


Q: Is there research evidence on Omeprazol Sandoz use in patients with liver impairment?

Yes. Regulatory guidance addresses the use of the medicine in patients with hepatic impairment (liver damage). Because the drug is mainly metabolized by the liver, official information notes that special considerations regarding the dose may apply.


Q: Why do people sometimes mention rebound acid when stopping Omeprazole?

The term rebound acid hypersecretion refers to a temporary, heightened increase in acid production that can happen shortly after stopping the medicine. This may cause a return of symptoms that can be more pronounced than before treatment, and it is a common factor discussed in guidelines for safely discontinuing acid-suppressive therapies.


Q: How does Omeprazol Sandoz compare to over-the-counter antacids?

Omeprazole is a Proton Pump Inhibitor (PPI) that works by reducing the actual amount of acid the stomach produces, which provides prolonged acid control. In contrast, standard over-the-counter antacids work by neutralizing the acid that is already present in the stomach, offering rapid but shorter-term relief from discomfort.


Q: Is it normal to experience gas or bloating when taking Omeprazol Sandoz?

Yes, it is documented as a Common occurrence. The official safety profile includes flatulence (gas) and abdominal pain as frequently reported adverse reactions, which are symptoms that may be associated with the sensation of bloating.


Q: Does Omeprazol Sandoz affect the absorption of other medications?

Yes. The primary mechanism of interaction is that Omeprazole significantly reduces stomach acid. By doing so, it can alter the absorption of other medicines that require an acidic pH level to dissolve properly and be absorbed into the body, such as certain antifungal and antiviral agents.


Q: What are the serious, but less common, side effects listed for Omeprazol Sandoz?

Serious, less common adverse effects documented in the safety profile include severe, widespread immune responses like anaphylactic shock and severe skin reactions such as Stevens-Johnson syndrome (SJS). Other rare, but serious, effects include severe blood changes and liver-related disorders like hepatitis.


Q: Can people with allergies to similar medicines use Omeprazol Sandoz?

No. The medicine is strictly contraindicated (must not be used) in patients with a known hypersensitivity to the active substance, omeprazole, to any of the ingredients in the formulation, or to other drugs in the substituted benzimidazole class (which includes other PPIs).


Q: Does taking Omeprazol Sandoz affect the immune system?

Official safety information documents rare, but serious, effects on the blood and immune-related cells. These include a severe decrease in certain white blood cells ( leukopenia or agranulocytosis) and severe hypersensitivity reactions. These are considered adverse effects that are documented in the safety profile.


Q: Is there a link between Omeprazol Sandoz and an increased risk of pneumonia?

Some regulatory warnings note that the use of Omeprazol may be associated with an increased risk of community-acquired pneumonia ( CAP). This potential link is thought to be related to the reduction of gastric acid allowing for changes in the natural balance of bacteria in the upper digestive tract.


Q: How is the drug stability or shelf life of Omeprazol Sandoz described?

Regulatory guidelines describe that the medicine must be stored under specific conditions to maintain its stability until its defined expiry date (shelf life). It is required to be kept at a controlled room temperature, protected from moisture, and stored in its original container with the lid tightly closed.

Advertisements

How should Omeprazol Sandoz be stored and disposed of?

How to Store and Dispose of Omeprazol Sandoz?

The official regulatory guidelines define strict rules for maintaining the stability of omeprazole. The medication must be stored at a controlled room temperature, typically below 25 C or 30 C, depending on the formulation. Protection from moisture is a mandatory requirement, which is achieved by keeping the medicine in its original package or ensuring the bottle is tightly closed.

All omeprazole products must be stored out of the sight and reach of children to prevent accidental ingestion. For disposal, unused or expired medication should not be flushed down the toilet or poured down a drain. Instead, it should be disposed of according to local pharmaceutical waste programs or safe household guidelines, as outlined by national regulatory bodies.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Omeprazol Sandoz found in:

A-Z Index: